search
Back to results

A Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African Women (Masibambane)

Primary Purpose

HIV Infections

Status
Active
Phase
Phase 1
Locations
South Africa
Study Type
Interventional
Intervention
Gender-Enhanced -- Masibambane
Individually accessed
Sponsored by
New York State Psychiatric Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for HIV Infections focused on measuring Pre-Exposure Prophylaxis, oral, South African, Adolescent girls and young women, HIV prevention

Eligibility Criteria

18 Years - 25 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. self-reported HIV-negative or unknown status
  2. heterosexual vaginal or anal intercourse reported in the past 6 months
  3. Is not currently taking PrEP or planning to begin PrEP
  4. presently residing in eThekweni-metropolitan Durban
  5. has private smart-phone access
  6. Conversant in isiZulu or English
  7. Willing to recruit other women (if in first group of participants);
  8. (If recruited subsequent to first group): Recruited by a peer health advocate (someone the participant knew knew prior to being recruited)

Exclusion Criteria:

  1. Overt signs of cognitive impairment
  2. Was a participant in the previously conducted focus groups
  3. If assigned to the online group intervention, unwilling to be audio-recorded

Sites / Locations

  • South African Medical Research Council

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Other

Arm Label

Masibambane - Gender-Enhanced

Individually accessed

Arm Description

A virtual (online) group-based interactive Gender-Enhanced (GE) Workshop (using the WhatsApp® platform). The intervention has components that are conducted by participants on their own time as well as a "real-time" "live" interactive session.

In this condition women are given access to a PrEP video and to websites that provide information on PrEP and on contraception options.

Outcomes

Primary Outcome Measures

Percent of participants who have an individual counseling session about PrEP.
Percent of all participants who request and undergo an individual counseling session with the study nurse about the possibility of taking up PrEP. This behavioral measure will be documented by the study nurse

Secondary Outcome Measures

Percent of participants who undergo HIV-testing and counseling (HCT).
Percent of all participants who undergo HIV testing and counseling, using self-administered OraQuick, either on her own or with study nurse support. This behavioral measure will be documented by the study nurse.
Percent taking up PrEP
If participant is PrEP-eligible (HIV-negative) she initiates PrEP. This outcome will be based on self-report.

Full Information

First Posted
March 21, 2021
Last Updated
June 28, 2022
Sponsor
New York State Psychiatric Institute
Collaborators
Medical Research Council, South Africa, Brown University
search

1. Study Identification

Unique Protocol Identification Number
NCT04833127
Brief Title
A Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African Women
Acronym
Masibambane
Official Title
Developing a Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African Women
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 30, 2021 (Actual)
Primary Completion Date
June 24, 2022 (Actual)
Study Completion Date
December 31, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
New York State Psychiatric Institute
Collaborators
Medical Research Council, South Africa, Brown University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a phase 1 pilot study to assess feasibility and acceptability and potential for impact of a gender-enhanced virtual group workshop focused on oral Pre-Exposure Prophylaxis (PrEP) as an HIV prevention method for young South African women. It was developed in collaboration with South African adolescent girls and young women (AGYW) aged 18-25. The investigators will compare AGYW (N=100) assigned to the virtual group-based (GE) workshop to those assigned to an Individually Accessed (IA) condition in which women are given access to a PrEP video and to websites that provide information on PrEP and on contraception options. Investigators also are evaluating the acceptability and feasibility of peer-driven recruitment (PDR). AGYW assigned to either intervention condition will be invited to become Peer Health Advocates (PHAs), who are incentivized to talk to social network members and refer up to three to the intervention type the PHA attended. The aim is to assess if PDR is self-sustaining and is effective at reaching women who might not be reached in clinics.
Detailed Description
South African adolescent girls and young women (AGYW) remain at extraordinarily high risk of HIV infection. Oral pre-exposure prophylaxis (PrEP) has the potential to alter the epidemic in this vulnerable population, given that it is has been shown that if it is adhered to, oral PrEP can protect women from HIV infection. Yet, a critical question is whether AGYW will adopt and adhere to oral PrEP. The investigators propose that two innovations can reach young, at-risk AGYW, inform them about PrEP and motivate them to use it: (1) introducing PrEP through a gender lens in a group workshop; and (2) peer-driven recruitment-recruiting women to attend the workshop by those who have already attended it. To inform intervention development, the investigators conducted six focus groups with at-risk AGYW (aged 18-25), 8 qualitative interviews with focus group participants, and 20 qualitative interviews with men (10 HIV-positive, 10 HIV-negative or of unknown status) partnered with women in this age range that explored knowledge of, beliefs about, motivators for, and concerns about using PrEP in the context of gendered relationship dynamics and PrEP-related stigma. Guided by gender theory and the Information Motivation Behavior (IMB) model, and in collaboration with a Working Group of AGYW, a virtual (online) group-based Gender-Enhanced (GE) Workshop (using the WhatsApp® platform) was developed. The intervention has components that are conducted by participants on their own time as well as a "real-time" "live" interactive session and aims to provide PrEP information and address AGYW's barriers to using it. The goal of the intervention is to promote consideration of and uptake of PrEP. In this phase 1 pilot study to assess feasibility and acceptability and potential for impact of the workshop, investigators will compare AGYW (N=100) assigned to the virtual group-based (GE) workshop or to an Individually Accessed (IA) condition in which women are given access to a PrEP video and to websites that provide information on PrEP and on contraception options. To evaluate Peer-driven recruitment (PDR), AGYW randomized to either condition will be invited to become Peer Health Advocates (PHAs), who are incentivized to talk to social network members and refer up to three to the workshop type the PHA attended. Acceptability and feasibility of PDR will be evaluated by assessing whether the method can be self-sustaining (i.e., on average >50% attendees become PHAs and >2 recruitees/PHA attend a workshop); and whether it reaches high-risk women and women who would not be captured by other methods of recruitment (percent who score high on HIV risk; percent who never tested or attended family planning). If promising, these approaches will be further tested in a larger study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections
Keywords
Pre-Exposure Prophylaxis, oral, South African, Adolescent girls and young women, HIV prevention

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Masibambane - Gender-Enhanced
Arm Type
Active Comparator
Arm Description
A virtual (online) group-based interactive Gender-Enhanced (GE) Workshop (using the WhatsApp® platform). The intervention has components that are conducted by participants on their own time as well as a "real-time" "live" interactive session.
Arm Title
Individually accessed
Arm Type
Other
Arm Description
In this condition women are given access to a PrEP video and to websites that provide information on PrEP and on contraception options.
Intervention Type
Behavioral
Intervention Name(s)
Gender-Enhanced -- Masibambane
Intervention Description
The intervention has components that provide PrEP information, provide information about HIV prevention and contraceptive options, prompt women to think about why they may be at risk for HIV, discuss women's sexual rights, and discuss how women can talk to their male partners about PrEP. The components are conducted by participants on their own time as well as during a "real-time" "live" interactive session with trained facilitators.
Intervention Type
Behavioral
Intervention Name(s)
Individually accessed
Intervention Description
The intervention includes an individually-accessed online PrEP video and South African government websites on PrEP and on contraception options
Primary Outcome Measure Information:
Title
Percent of participants who have an individual counseling session about PrEP.
Description
Percent of all participants who request and undergo an individual counseling session with the study nurse about the possibility of taking up PrEP. This behavioral measure will be documented by the study nurse
Time Frame
Immediate post-intervention up to 3 months after the intervention (i.e., as reported on the 3-month follow-up)
Secondary Outcome Measure Information:
Title
Percent of participants who undergo HIV-testing and counseling (HCT).
Description
Percent of all participants who undergo HIV testing and counseling, using self-administered OraQuick, either on her own or with study nurse support. This behavioral measure will be documented by the study nurse.
Time Frame
Immediate post-intervention up to 3 months after the intervention
Title
Percent taking up PrEP
Description
If participant is PrEP-eligible (HIV-negative) she initiates PrEP. This outcome will be based on self-report.
Time Frame
Immediate post-intervention up to 3 months after the intervention
Other Pre-specified Outcome Measures:
Title
Number of correct reponses on PrEP information scale
Description
5-item scale developed for this study. Count of correct responses
Time Frame
baseline to immediate post-intervention and 3 month follow-up
Title
Mean value on Perceived risk for HIV scale
Description
8-item measure from Napper LE, Fisher DG, Reynolds GL. Development of the perceived risk of HIV scale. AIDS and Behavior. 2012;16(4):1075-83.
Time Frame
baseline to immediate post-intervention and 3 month follow-up
Title
Mean value on Perceived effectiveness of PrEP scale
Description
10-item measure from Golub et al., Predictors of PrEP Uptake AIDS and Behavior 2019 23:1917-1924.
Time Frame
baseline to immediate post-intervention and 3 month follow-up
Title
Mean value on Positive outcomes of taking PrEP scale
Description
5-item measure from Teitelman et al., 2020 Beliefs associated with intention to use PrEP among cis-gender US women at risk: Archives of Sexual Behavior (2020) 49:2213-2221.
Time Frame
baseline to immediate post-intervention and 3 month follow-up
Title
Mean value on PrEP anticipated stigma, PrEP-user stereotypes subscale
Description
The PrEP Anticipated Stigma Scale- PrEP-User Stereotypes subscale. from Calabrese et al. HIV Pre-Exposure Prophylaxis Stigma as a Multidimensional Barrier to Uptake Among Women Who Attend Planned Parenthood J Acquir Immune Defic Syndr 2018;79:46-53.
Time Frame
baseline to immediate post-intervention and 3 month follow-up
Title
Mean value on PrEP Anticipated stigma, Disapproval by others subscale
Description
The PrEP Anticipated Stigma Scale- Disapproval by others subscale. from Calabrese et al.J Acquir Immune Defic Syndr 2018;79:46-53
Time Frame
baseline to immediate post-intervention and 3 month follow-up
Title
Mean value on Medication beliefs
Description
4-item scale adapted from adapted from Kalichman et al. Medication Beliefs and Structural barriers to Treatment Adherence Among People Living with HIV Infection. Psychol Health. 2016 April ; 31(4): 383-395.
Time Frame
baseline to immediate post-intervention and 3 month follow-up
Title
Mean value on gendered partner disclosure beliefs
Description
5-item measure developed by the team for this study
Time Frame
baseline to immediate post-intervention and 3 month follow-up
Title
Increase in value on Stage of change scale
Description
Stages of Change based on Prochaska, J. O., & Norcross, J. C. (2002). Stages of Change. In J. C. Norcross (Ed.), Psychotherapy relationships that work: Therapist contributions and responsiveness to patients (p. 303-313). Oxford University Press.
Time Frame
baseline to immediate post-intervention and 3 month follow-up

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Based on self-representation of gender identity
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: self-reported HIV-negative or unknown status heterosexual vaginal or anal intercourse reported in the past 6 months Is not currently taking PrEP or planning to begin PrEP presently residing in eThekweni-metropolitan Durban has private smart-phone access Conversant in isiZulu or English Willing to recruit other women (if in first group of participants); (If recruited subsequent to first group): Recruited by a peer health advocate (someone the participant knew knew prior to being recruited) Exclusion Criteria: Overt signs of cognitive impairment Was a participant in the previously conducted focus groups If assigned to the online group intervention, unwilling to be audio-recorded
Facility Information:
Facility Name
South African Medical Research Council
City
Durban
State/Province
KwaZulu-Natal
Country
South Africa

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35306944
Citation
Harrison A, Bhengu N, Miller L, Exner T, Tesfay N, Magutshwa S, Khumalo S, Bergam S, Hoffman S, Hanass-Hancock J. "You tell him that 'baby, I am protecting myself'": Women's agency and constraint around willingness to use pre-exposure prophylaxis in the Masibambane Study. Womens Health (Lond). 2022 Jan-Dec;18:17455057221087117. doi: 10.1177/17455057221087117.
Results Reference
background
PubMed Identifier
35218452
Citation
Bergam S, Harrison AD, Benghu N, Khumalo S, Tesfay N, Exner T, Miller L, Dolezal C, Hanass-Hancock J, Hoffman S. Women's Perceptions of HIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa. AIDS Behav. 2022 Sep;26(9):2881-2890. doi: 10.1007/s10461-022-03632-6. Epub 2022 Feb 26.
Results Reference
background

Learn more about this trial

A Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African Women

We'll reach out to this number within 24 hrs